Aura Biosciences, Inc. Common Stock

AURANASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
7.00 USD
↗ 0.14 (2.04%)AT CLOSE (11:59 AM EDT)
7.00
↘ 0.01 (0.07%)
POST MARKET (AS OF 07:33 PM EDT)
Post Market
AS OF 07:33 PM EDT
7.00
↘ 0.01 (0.07%)
🔴Market: CLOSED

AURA is currently priced at $7.00. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. AURA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 26, 2026.

Open?$6.86
High?$7.08
Low?$6.78
Prev. Close?$6.86
Volume?1.6M
Avg. Volume?569.9K
VWAP?$6.96
Rel. Volume?2.86x
Bid / Ask
Bid?$5.99 × 500
Ask?$8.00 × 100
Spread?$2.01
Midpoint?$7.00
Valuation & Ratios
Market Cap?723.7M
Shares Out?103.4M
Float?44.2M
Float %?68.9%
P/E Ratio?N/A
P/B Ratio?6.75
EPS?-$1.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
113
Market Cap
709.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.aurabiosciences.com
Listed
2021-10-29
Address
80 GUEST STREET
BOSTON, MA 02135
Phone: (617)500-8864
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
77
Short Sent.?
18
Piotroski F-Score?0/9Weak
Altman Z-Score?7.09Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?12.18%High
Short Interest?5.4M
Days to Cover?10.3
Free Float44.2M
Avg Daily Volume521.9K
Settlement Date2026-06-15
Financial Health
Current Ratio?7.09Strong
Quick Ratio?7.09Strong
Cash Ratio?5.08Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
28
6.75FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-5.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-104.8%WEAK▾
ROA?
S&P
3
-81.6%WEAK▾
Cash Flow & Enterprise
FCF?$-91642000
Enterprise Value?$638.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist